Browse > Article
http://dx.doi.org/10.9721/KJFST.2012.44.4.428

Cognitive-enhancing Effects of a Fermented Milk Product, LHFM on Scopolamine-induced Amnesia  

Jeon, Yong-Jin (LDONG Research Laboratories, ILDONG Pharmaceutical Co. Ltd.)
Kim, Jun-Hyeong (LDONG Research Laboratories, ILDONG Pharmaceutical Co. Ltd.)
Lee, Myong-Jae (LDONG Research Laboratories, ILDONG Pharmaceutical Co. Ltd.)
Jeon, Woo-Jin (LDONG Research Laboratories, ILDONG Pharmaceutical Co. Ltd.)
Lee, Seung-Hun (LDONG Research Laboratories, ILDONG Pharmaceutical Co. Ltd.)
Yeon, Seung-Woo (LDONG Research Laboratories, ILDONG Pharmaceutical Co. Ltd.)
Kang, Jae-Hoon (LDONG Research Laboratories, ILDONG Pharmaceutical Co. Ltd.)
Publication Information
Korean Journal of Food Science and Technology / v.44, no.4, 2012 , pp. 428-433 More about this Journal
Abstract
Probiotics and their products, such as yogurt and cheese have been widely consumed in many countries with proven health benefits including anti-microbial activity and anti-diarrheal activity. LHFM (Lactobacillus helveticus - fermented milk) is a processed skim milk powder, fermented by a probiotics, L. helveticus IDCC3801. In the present study, we aimed to investigate the neuroprotective effects and the cognitive improvements of LHFM. LHFM itself did not show any cytotoxicity to the human neuroblastoma cell line, SH-SY5Y; however, it dose-dependently protected against glutamate-induced neuronal cell death. LHFM also attenuated scopolamine-induced memory deficit in Y-maze and Morris-water maze. In the analysis of hippocampus after a behavior test, LHFM significantly increased the acetylcholine level and also inhibited acetylcholine esterase activity. Therefore, the raised acetylcholine release partially contributes to the improvement of learning and memory by a treatment with LHFM. These results suggest that LHFM is an effective material for prevention or improvement of cognitive impairments caused by neuronal cell damage and central cholinergic dysfunction.
Keywords
Lactobacillus helveticus - fermented milk; Lactobacillus helveticus; acetylcholine; cognition; apoptosis;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Yeon SW, You YS, Kwon HS, Yang EH, Ryu JS, Kang BH, Kang JH. Fermented milk of Lactobacillus helveticus IDCC3801 reduces beta-amyloid and attenuates memory deficit. J. Funct. Foods 2: 143-152 (2010)   DOI
2 Morris R. Developments of a water-maze procedure for studying spatial learning in the rat. Neurosci. Methods 11: 47-60 (1984)   DOI
3 Yamaguchi Y, Miyashita H, Tsunekawa H, Mouri A, Kim HC, Saito K, Matsuno T, Kawashima S, Nabeshima T. Effects of a novel cognitive enhancer, spiro[imidazo-[1,2-a]pyridine-3,2-indan]-2(3H)-one (ZSET1446), on learning impairments induced by amyloid-beta1-40 in the rat. J. Pharmacol. Exp. Ther. 317: 1079-1087 (2006)   DOI
4 Lee B, Jung K, Kim DH. Timosaponin AIII, a saponin isolated from Anemarrhena asphodeloides, ameliorates learning and memory deficits in mice. Pharmacol. Biochem. Be. 93: 121-127 (2009)   DOI
5 Kwon SH, Lee HK, Kim JA, Hong SI, Kim HC, Jo TH, Park YI, Lee CK, Kim YB, Lee SY, Jang CG. Neuroprotective effects of chlorogenic acid on scopolamine-induced amnesia via anti-acetylcholinesterase and anti-oxidative activities in mice. Eur. J. Pharmacol. 649: 210-217 (2010)   DOI
6 Siesjö BK, Memezawa H, Smith ML. Neurotoxicity: Pharmacological implications. Fund. Clin. Pharmacol. 5: 755-767 (1991)   DOI
7 Choi DW. Possible mechanisms limiting N-methyl-D-aspartate receptor overactivation and the therapeutic efficacy of N-methyl-D-aspartate antagonists. Stroke 20: lll20-22 (1990)
8 Michael TL, M. Flint Beal. Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature 443: 787-795 (2006)   DOI
9 Kalman J, Engelhardt JI, Le WD, Xie W, Kovacs I, Kasa P, Appel SH. The cholinergic system in aging and neuronal degeneration. J. Neuroimmunol. 77: 63-74 (1997)   DOI
10 Snow RE, Arnold SE. Psychosis in neurodegenerative disease. Semin. Clin. Neuropsychiatry 1: 282-293 (1996)
11 Kidd PM. Alzheimer's disease, amnestic mild cognitive impairment, and age-associated memory impairment: Current understanding and progress toward integrative prevention. Altern. Med. Rev. 13: 85-115 (2008)
12 McNally RJ. Experimental approaches to cognitive abnormality in posttraumatic stress disorder. Clin. Psychol. Rev. 18: 971-982 (1998)   DOI
13 Welch KA. Neurological complications of alcohol and misuse of drugs. Pract. Neurol. 11: 206-219 (2011)   DOI
14 Vakil E. The effect of moderate to severe traumatic brain injury (TBI) on different aspects of memory: A selective review. J. Clin. Exp. Neuropsychol. 27: 977-1021 (2005)   DOI
15 Deutsch JA. The cholinergic synapse and the site of memory. Science 174: 788-794 (1971)   DOI
16 Davies P, Maloney AF. Selective loss of central cholinergic neurons in Alzheimer's disease. Lancet 2: 1403-1410 (1976)
17 Bartus RT, Dean RL, Beer B, Lippa AS. The cholinergic hypothesis of geriatic memory dysfunction. Science 217: 408-414 (1982)   DOI
18 Usinger L, Ibsen H, Jensen LT. Does fermented milk possess antihypertensive effect in humans? J. Hypertens. 27: 1115-1120 (2009)   DOI
19 Whitehouse PJ, Price DL, Clark AW, Coyle JT, DeLong MR. Alzheimer's disease: Evidence of selective loss of cholinergic neurons in the nucleus basalis. Ann. Neurol. 10: 408-414 (1981)
20 Coyle JT, Price DL, DeLong MR. Alzheimer's disease: A disorder of cortical cholinergic innervation. Science 219: 1184-1190 (1983)   DOI
21 Naidu AS, Bidlack WR, Clemens RA. Probiotic spectra of lactic acid bacteria (LAB). Crit. Rev. Food Sci. 39: 13-126 (1999)   DOI
22 Bengmark S. Bio-ecological control of chronic liver disease and encephalopathy. Metab. Brain Dis. 24: 223-236 (2009)   DOI
23 Li H, Cao Y. Lactic acid bacterial cell factories for gamma-aminobutyric acid. Amino Acids 39: 1107-1116 (2010)   DOI